Company | Ticker | Business Description | Underwriters | Offer Date |
---|---|---|---|---|
Prometheus Biosciences> | RXDX> | Phase 1 biotech developing precision antibody therapies for IBD and related diseases. | Leerink Partners Credit Suisse |
03/11/21 |
News Results for rxdx |
---|